Dea Belazi Dea Belazi

Dea Belazi, PharmD, MPH is President & CEO at AscellaHealth, a national PBM with almost two million lives under management. Dea has more than 20 years of experience in the healthcare industry, mostly developing and managing pharmacy benefit management companies.

340B Cuts Could Impact Access to Specialty Drugs

For more than 25 years, the 340B Drug Pricing Program1 has helped safety-net facilities ...

Pharma Must Demonstrate Better Outcomes for Pay-Per-Performance

In the dramatically changing pharma industry, one key trend that overlays providers of care, ...

The World’s Most Expensive Drug

Priced at a staggering $2.125 million per patient,  Zolgensma is now the world’s most ...

Changes to Medicare Part D Continue to Evolve

With the Bipartisan Budget Act of 2018 (BBA), Congress made changes to the Medicare ...